2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Lateral shifting from apomorphine subcutaneous infusion (ASI) to levodopa-carbidopa intestinal gel (LCIG) in the treatment of advanced idiopathic Parkinson’s disease (PD): Case series

M. Abu Al-Melh, M. Farghal, N. Abdelall (Ahmadi governorate, Kuwait)
Leading Therapeutic Molecules Target Transcription Factors Binding to Repressor Region in FXN Gene

V. Swarup, H. Singh, D. Gupta, I. Singh, A. Srivastava (New Delhi, India)
Learning to PERSEVERE: Efficacy and Feasibility of Peer Mentor Support and Caregiver Education in Lewy Body Dementia

J. Fleisher, F. Akram, S. Hess, M. Levin, D. Dodson, G. Stebbins, M. Tosin, B. Ouyang, J. Chodosh (Chicago, USA)
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: the PD COMM randomised controlled trial.

C. Sackley, C. Rick, S. Patel, R. Woolley, M. Brady, A. Nicoll, S. Dickson, G. Beaton, C. Smith, H. Nankervis, C. Burton, P. Masterson-Algar, N. Ives, S. Jowett, Z. Abdali, L. Sharp, T. Jeffreys, C. Clarke (London, United Kingdom)
Lentiform fork sign and Wilson Disease

JL. Freitas, MS. Rocha, PC. Matos, I. Torres, L. Corazza, JF. Tasch (São Paulo, Brazil)
Lesion-induced chorea-ballismus in Southwest Finland

E. Mäkinen, J. Joutsa (Turku, Finland)
Level of glial neurotrophic factor in the blood plasma depending on the duration of Parkinson’s disease

B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)
Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson’s disease- First case series from Middle-East Region

S. Mittal, A. Aldakheel, W. Mohammed, T. Alkhairallah, B. Klassen, M. Thomas, T. Maiti, S. Wasti (Abu Dhabi, United Arab Emirates)
Levodopa Pharmacokinetics in Different Levodopa Treatment Regimens plus Opicapone in Parkinson’s Disease Patients with Motor Fluctuations

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Levodopa-carbidopa intestinal gel (LCIG) as an add-on therapy to deep brain stimulation (DBS) for managing progressive symptoms of advanced idiopathic Parkinson’s disease during the COVID-19 pandemic: Case Report

M. Abu Al-Melh, M. Farghal, N. Abdelall (Ahmadi governorate, Kuwait)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z